A Single Center Pilot Study to Assess the Intra-observer Reliability of Measuring Muscle Strength Using a Hand Held Dynamometer in Children and Adults With Neurofibromatosis Type 1 (NF1) and Type 2 (NF2)
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
NYU Langone Health
Age
5–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
For cohort 1:
* Patients must have clinically confirmed NF1 using the NIH consensus criteria or a known NF1 mutation
* Ages 5 years and above
* \< 5/5 strength on Manual Muscle Testing (MMT) testing in at least one muscle group tested on the day of enrollment
* Able to follow instructions and cooperate with exam to assess strength
For Cohort 2
* Patients must have clinically (NIH or Manchester criteria) or genetically confirmed diagnosis of NF2
* Ages 5 years and above
* \< 5/5 strength on MMT testing in at least one muscle group tested on the day of enrollment
* Able to follow instructions and cooperate with exam to assess strength
You may not be if
No orthopedic procedure or other major surgery that could influence extremity strength in past 6 months
No tibial dysplasia
Clareo Health | A Single Center Pilot Study to Assess the Intra-observer Reliability of Measuring Muscle Strength Using a Hand Held Dynamometer in Children and Adults With Neurofibromatosis Type 1 (NF1) and Type 2 (NF2)
